It is also known that the effects of HCM and DCM mutations on the Ca2+-sensitivity can be modulated by phosphorylation of sarcomeric proteins, especially of cTnI and cMyBPC [26, 40–43]. This evidence concerns the gene MYBPC3 and familial dilated cardiomyopathy.